154 related articles for article (PubMed ID: 36305800)
1. Development and characterization of an amorphous curcumin-Eudragit
Wang X; Zhu Y; Zhao X; Zhang S; Cao M; Wang X; Li W
Pharm Dev Technol; 2022 Nov; 27(9):965-974. PubMed ID: 36305800
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-Eudragit® E PO solid dispersion: A simple and potent method to solve the problems of curcumin.
Li J; Lee IW; Shin GH; Chen X; Park HJ
Eur J Pharm Biopharm; 2015 Aug; 94():322-32. PubMed ID: 26073546
[TBL] [Abstract][Full Text] [Related]
3. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
4. Storage stability and solubilization ability of HPMC in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Ma P; Wang X; Li C; Zhang X; Zhang K; Li J; He Z
Carbohydr Polym; 2018 Nov; 199():492-498. PubMed ID: 30143154
[TBL] [Abstract][Full Text] [Related]
5. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
Meng F; Trivino A; Prasad D; Chauhan H
Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Curcumin-Eudragit
Fan W; Zhang X; Zhu W; Zhang X; Di L
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443551
[TBL] [Abstract][Full Text] [Related]
7. [Effect of HPMCAS/curcumin amorphous solid dispersion in enhancing dissolution and chemical stability of curcumin].
Liang Q; Wang YR; Deng YY
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(15):3305-3311. PubMed ID: 31602887
[TBL] [Abstract][Full Text] [Related]
8. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.
Li J; Wang X; Li C; Fan N; Wang J; He Z; Sun J
Mol Pharm; 2017 Aug; 14(8):2781-2792. PubMed ID: 28661679
[TBL] [Abstract][Full Text] [Related]
9. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
[TBL] [Abstract][Full Text] [Related]
10. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
Fan N; Lu T; Li J
J Pharm Sci; 2020 Feb; 109(2):1068-1078. PubMed ID: 31639390
[TBL] [Abstract][Full Text] [Related]
11. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion.
Wan S; Sun Y; Qi X; Tan F
AAPS PharmSciTech; 2012 Mar; 13(1):159-66. PubMed ID: 22173375
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
Obeidat WM; Nokhodchi A; Alkhatib H
AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
[TBL] [Abstract][Full Text] [Related]
13. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
14. Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach.
Medarević D; Cvijić S; Dobričić V; Mitrić M; Djuriš J; Ibrić S
Eur J Pharm Sci; 2018 Nov; 124():188-198. PubMed ID: 30144529
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Dissolution and Bioavailability of Curcumin Nanocrystals Prepared by Hot Melt Extrusion Technology.
Zhao Y; Xu X; Dai A; Jia Y; Wang W
Int J Nanomedicine; 2024; 19():5721-5737. PubMed ID: 38895153
[TBL] [Abstract][Full Text] [Related]
17. Enhanced bioavailability of curcumin amorphous nanocomposite prepared by a green process using modified starch.
Chen C; Wang Z; Fu H; Yu G; Luo X; Zhu K
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132210. PubMed ID: 38729473
[TBL] [Abstract][Full Text] [Related]
18. Improved Oral Absorption of Poorly Soluble Curcumin via the Concomitant Use of Borneol.
Gao Y; Chen G; Luan X; Zou M; Piao H; Cheng G
AAPS PharmSciTech; 2019 Mar; 20(4):150. PubMed ID: 30903519
[TBL] [Abstract][Full Text] [Related]
19. Surfactant-free solid dispersion of BCS class IV drug in an amorphous chitosan oligosaccharide matrix for concomitant dissolution in vitro - permeability increase.
Huang R; Han J; Wang R; Zhao X; Qiao H; Chen L; Li W; Di L; Zhang W; Li J
Eur J Pharm Sci; 2019 Mar; 130():147-155. PubMed ID: 30699368
[TBL] [Abstract][Full Text] [Related]
20. Involvement of metabolism-permeability in enhancing the oral bioavailability of curcumin in excipient-free solid dispersions co-formed with piperine.
Wang R; Han J; Jiang A; Huang R; Fu T; Wang L; Zheng Q; Li W; Li J
Int J Pharm; 2019 Apr; 561():9-18. PubMed ID: 30817985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
